The Gene Therapy for Parkinson’s Disease market size is expected to reach $2.05 billion in 2030 at a CAGR of 26.0%, driven by growing interest in personalized medicine.
Read More
The Gene Therapy for Inherited Genetic Disorders market size is expected to reach $9.69 billion in 2030 at a CAGR of 19.0%, driven by rising personalized medicine demand.
Read More
The Gene Therapy market size is expected to reach $35.61 billion in 2030 at a CAGR of 13.5%, driven by rising healthcare industry investment.
Read More
The global Gene Synthesis market size is expected to reach $10.44 billion in 2030 at a CAGR of 21.7%, driven by rising biofuel demand.
Read More
The Gene Silencing market size is expected to reach $12.1 billion in 2030 at a CAGR of 12.6%, driven by rising prevalence of genetic disorders.
Read More
The Gene Expression market size is expected to reach $22.22 billion in 2030 at a CAGR of 11.9%, driven by rising chronic diseases.
Read More
The Gene Circuit Therapeutics market size is expected to reach $5.03 billion in 2030 at a CAGR of 22.3%, driven by growing demand for personalized medicine.
Read More
The Gemcitabine Hydrochloride market size is expected to reach $1.15 billion in 2030 at a CAGR of 6.6%, driven by rising breast cancer incidence.
Read More
The G-CSF (Granulocyte Colony Stimulating Factors) market size is expected to reach $12.21 billion in 2030 at a CAGR of 5.3%, driven by rising cancer prevalence.
Read More
The Gastroparesis Drugs market size is expected to reach $7.37 billion in 2030 at a CAGR of 5.2%, driven by rising diabetes prevalence.
Read More